Medical Marijuana Dispensary Business Project 1493, LLC Announces Share Exchange Agreement with Public Entity & Simultaneous $3.3 Million PIPE Financing

Press Release – June 15, 2017 –– New York, NY – Sichenzia Ross Ference Kesner LLP (“SRFK”) announced today that the Firm has represented Project 1493, LLC in a share exchange agreement with Green Spirit Industries Inc. (GSRX: OTC).

Project 1493’s business relates to the acquisition, development, and operation of medical marijuana dispensaries in Puerto Rico. Simultaneously with the share exchange, SRFK advised GSRX on a private offering for gross proceeds of $3.3 million consisting of 8,461,538 shares of common stock and warrants to purchase up to 2,538,462 shares of common stock at an exercise price of $0.50. The transaction closed on May 11, 2017.

The Sichenzia Ross Ference Kesner LLP team was led by Partner Darrin M. Ocasio, Counsel Cheryll Calaguio, and Associate S. Ashley Jaber.

• About
• Latest Posts

Sichenzia Ross Ference LLP

Sichenzia Ross Ference LLP is a nationally recognized securities and corporate law firm that provides experienced representation in all matters involving the securities industry. Super Lawyers consistently recognizes our attorneys as among the highest rated securities lawyers in the nation. Our attorneys specialize in advising clients on private placements, initial (IPOs) and secondary public offerings, alternative public offerings, preparation of SEC filings and listings on major capital stock exchanges such as the NYSE (New York Stock Exchange), NASDAQ and OTC markets. In addition, our litigation and arbitration attorneys are highly skilled in representing clients from routine lawsuits to complex cases before the SEC, FINRA and other tribunals. We also represent clients in a range of residential and commercial real estate and trusts and estates matters.

Visit SRF's LinkedIn page

Latest posts by Sichenzia Ross Ference LLP (see all)

• Attorneys Selected for Inclusion on 2019 Super Lawyers Lists - October 16, 2019
• Sichenzia Ross Ference LLP to Join Client Relmada Therapeutics, Inc. at Nasdaq Opening Bell Ringing - October 15, 2019
• Sichenzia Ross Ference LLP Congratulates Relmada Therapeutics, Inc., on NASDAQ Uplisting - October 10, 2019